IBD biomarker discovery study
Part of Digestive system clinical trials.
This study collects blood, stool, tissue, and health information from people with inflammatory bowel disease (IBD), their relatives, and healthy volunteers to find patterns that may help diagnose or treat IBD better in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 14 or older
- Diagnosed with Crohn's disease, ulcerative colitis, or IBD-unclassified, OR be a close family member of someone with IBD, OR be a healthy person without IBD
- Willing to give samples (blood, stool, or tissue) and share medical information
- Not have active serious infections like tuberculosis, hepatitis B or C, or HIV
- Not be pregnant or breastfeeding
- Not have a major illness like cancer or a severe mental health condition that would interfere
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have a parent, sibling, or child with Crohn's disease or ulcerative colitis to help understand why some family members develop the condition. If you are 14 or older and do not already have IBD, you may be able to join.
This study looks at using precision medicine to treat inflammatory bowel disease (IBD) in people who are newly diagnosed or already being monitored. It aims to find better ways to manage the condition.
This study follows people with Crohn's disease or ulcerative colitis (and healthy volunteers) to understand what affects the disease's progression and complications. It looks at factors like your gut bacteria and immune treatments.
This trial looks at early signs of inflammatory bowel disease (IBD) in adults who have had stomach or bowel symptoms for at least 3 weeks. It aims to understand how the disease progresses.
This study looks at healthy family members of people with Crohn's disease or ulcerative colitis to find early signs of these conditions before symptoms appear. It may help doctors predict and prevent inflammatory bowel disease.
This study tests non-invasive tools to find active inflammation in people with Crohn's disease or ulcerative colitis. You may need to give extra stool samples before your colonoscopy and calprotectin test.
Hear when a new Crohn Disease (CD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.